RHP 0.85% $1.76 rhipe limited

Depends what 2017 guidance metrics you use: Reported EBITDA $4m...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 300 Posts.
    lightbulb Created with Sketch. 11
    Depends what 2017 guidance metrics you use:

    Reported EBITDA $4m = EV / EBITDA x 12
    Reported NPAT $2.3m = P/E x 26 and P/EV x 21
    or
    Underlying EBITDA $8m = EV / EBITDA x 6
    Underlying NPAT $5m = P/E x 12 and P/ EV x 9

    Underlying is the cheap metric but requires a leap of faith as it excludes key factors:
    - Bonuses / Stock-Based Payments, Restructuring, Integration, Transaction, Due Diligence Expenses
    - Asian Country Start Up Losses
    - Vendor Growth Program Losses

    Reported EBITDA vs Underlying EBITDA:
    2014: 1.4 vs $3.3m
    2015: -$1.3m vs $4.9m
    2016: $1.4m vs $5.1m
    2017: $4m vs $8m (guidance)

    Licencing Gross Margin:
    2014: 16%
    2015: 15%
    2016: 14%
    2017: 15% (H1)

    Group Expenses:
    2014: $10m
    2015: $19m
    2016: $25m
    2017: $26m (guidance)

    Absolutely key for those 2017 figures to be met as they significantly affect price valuations and business model viability.
 
watchlist Created with Sketch. Add RHP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.